| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8807348 | Diagnostic Histopathology | 2017 | 11 Pages |
Abstract
The benefits of large scale sequencing studies of sarcoma are leading to new insights into sarcoma development and are providing a biological rationale for personalised medicine. Genomic profiling and other “omic” studies will likely play a fundamental part in the development of new diagnostic and predictive biomarkers in the near future.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Fernanda Amary, Nischalan Pillay, Adrienne M. Flanagan,